Phase 3 Readout~month

Phase 3 Topline: An Open-Label Extension Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term

Indication
Pulmonary Arterial Hypertension

Other upcoming events for INSM

Phase 3 ReadoutPhase 3 Topline: Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study to Evalua
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evalua
Phase 3 ReadoutPhase 3 Topline: A Long-term Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder for Treatment of P

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: An Open-Label Extension Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term — INSM Phase 3 Readout | BioSniper